Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0000921895-20-003108

Options or other derivatives

  • Chief Operating Officer acquired 2,400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Zanganeh Maky Chief Operating Officer 2020-11-22 Grant or award · Stock Option (right to buy) +2,400,000 3,724,499 D
Loading xslF345X03/form412566zan_11242020.xml…